- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant thymidine phosphorylase encapsulated in autologo
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes
| EU orphan designation number: | EU/3/11/856
|
| Active ingredient: | Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes |
| Indication: | Treatment of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) due to thymidine phosphorylase deficiency |
| Sponsor: | St George's University of London
Joint Research Office, Cranmer Terrace, London SW17 0RE, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 19/04/2011 | Orphan designation | EMA/OD/136/10 | (2011)2843 of 15/04/2011 |
CONTACT
EU links
Directorate General Health & Consumers